Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Study completedNCT02927301What this trial is testingAtezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)Who this might be right forNon-Small Cell Lung Cancer Genentech, Inc. 181
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07472478What this trial is testingPhase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12C-Mutant NSCLC (GIVEN Study)Who this might be right forLung Cancer (NSCLC)KRAS G12C Lung Cancer Guangdong Provincial People's Hospital 32
Testing effectiveness (Phase 2)Looking for participantsNCT06918132What this trial is testingCemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung CancerWho this might be right forLung Non-Small Cell CarcinomaStage IB Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8+2 more Mayo Clinic 60
Not applicableStudy completedNCT02728596What this trial is testingS1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)Who this might be right forFebrile NeutropeniaStage 0 Breast CancerStage 0 Colorectal Cancer+25 more SWOG Cancer Research Network 3,665
Early research (Phase 1)Active Not RecruitingNCT02321501What this trial is testingCeritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung CancerWho this might be right forALK PositiveLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm+3 more M.D. Anderson Cancer Center 37
Not applicableStudy completedNCT01999881What this trial is testingImpacts of Exercise on Prognostic Biomarkers in Lung Cancer PatientsWho this might be right forExtensive Stage Small Cell Lung CancerHealthy, no Evidence of DiseaseLimited Stage Small Cell Lung Cancer+9 more University of Wisconsin, Madison 21
Very early researchEnded earlyNCT01707823What this trial is testingLow-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung CancerWho this might be right forAdenocarcinoma of the LungRecurrent Non-small Cell Lung CancerStage IA Non-small Cell Lung Cancer+5 more Vanderbilt-Ingram Cancer Center 4
Early research (Phase 1)Ended earlyNCT01911325What this trial is testingPhase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) PatientsWho this might be right forSquamous Non-small Cell Lung Cancer Novartis Pharmaceuticals 27
Early research (Phase 1)Ended earlyNCT00856427What this trial is testingImplantation of Markers for the Radiotherapy of Lung Cancer PatientsWho this might be right forLung Cancer Virginia Commonwealth University 6
Large-scale testing (Phase 3)Looking for participantsNCT06431633What this trial is testingStudy of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.Who this might be right forLung DiseasesCarcinoma, Non-Small-Cell LungResectable Lung Non-Small Cell Carcinoma Fundación GECP 129
Early research (Phase 1)Study completedNCT02507375What this trial is testingPertuzumab With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 17
Testing effectiveness (Phase 2)Study completedNCT03758287What this trial is testingNingetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M NegativeWho this might be right forNon-small Cell Lung Cancer Sunshine Lake Pharma Co., Ltd. 108
Early research (Phase 1)Study completedNCT02364609What this trial is testingPembrolizumab and Afatinib in Patients With Non-small Cell Lung Cancer With Resistance to ErlotinibWho this might be right forRecurrent Non-Small Cell Lung CarcinomaStage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung Cancer+1 more Jonathan Riess 11
Large-scale testing (Phase 3)Active Not RecruitingNCT04428905What this trial is testingSelf-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal CancerWho this might be right forLung Non-Small Cell CarcinomaStage I Colorectal Cancer AJCC v8Stage I Lung Cancer AJCC v8+19 more City of Hope Medical Center 403
Testing effectiveness (Phase 2)Study completedNCT04770688What this trial is testingAdvanced Lung Tumor Treated by Osimertinib Plus AnlotinibWho this might be right forNon-Small Cell Lung Cancer With EGFR MutationLocally Advanced Solid TumorMetastatic Cancer+1 more Shanghai Chest Hospital 25
Early research (Phase 1)UnknownNCT00324597What this trial is testingAMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forLung CancerLymphomaLymphoproliferative Disorder+1 more Jonsson Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT07534033What this trial is testingPhase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung CancerWho this might be right forNSCLC Diagnosed by Histology or CytologyA Multidisciplinary Team Assessment Determined That the Patient Was a Suitable Candidate for Radical Surgical ResectionOverall Lung Function is Adequate for the Planned Lung Resection+1 more Zhujiang Hospital
Early research (Phase 1)Looking for participantsNCT03819296What this trial is testingRole of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerWho this might be right forClinical Stage 0 Cutaneous Melanoma AJCC v8Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage IA Cutaneous Melanoma AJCC v8+41 more M.D. Anderson Cancer Center 800
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130